Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
RVV Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cryoport Inc CYRX

Consumer Cyclical Technology Scientific & Technical Instruments Industrials
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its... see more

Recent & Breaking News (NDAQ:CYRX)

Cryoport Appoints Robert Hariri, MD, PhD to its Board of Directors

PR Newswire October 1, 2015

Cryoport Acquires Full IP Rights to Cryoportal(TM)

PR Newswire September 24, 2015

Cryoport Supports Opexa Therapeutics' Lead Personalized T-Cell Immunotherapy Programs

PR Newswire August 26, 2015

Cryoport Supports Stemedica's Ischemic-Tolerant Stem Cell Product Lines

PR Newswire August 18, 2015

Cryoport Reports 53% Revenue Growth for the First Quarter of Fiscal Year 2016

PR Newswire August 6, 2015

Cryoport to Report First Quarter Fiscal 2016 Financial Results

PR Newswire August 3, 2015

Cryoport Provides Cryogenic Logistics Solutions to HemaCare Corporation

PR Newswire July 30, 2015

Cryoport Completes $6.8 Million Equity Capital Raise

PR Newswire July 29, 2015

Cryoport's Portfolio of Temperature-Managed Clinical Programs Expands to 45 Trials

PR Newswire July 27, 2015

Cryoport Announces Pricing of Public Offering of Units and Listing on NASDAQ

PR Newswire July 23, 2015

ZenBio Engages Cryoport to Support Distribution of its Human Cell-Based Products

PR Newswire July 14, 2015

Cryoport Selected for Logistics Support of CaRE Arthritis Personalized Medicine Efforts

PR Newswire June 17, 2015

Cryoport Selected by Lynden International as the Preferred Cryogenic Logistics Provider

PR Newswire June 10, 2015

Cryoport Supports ArunA Biomedical's Cryogenic Shipments of Stem Cell Kits

PR Newswire June 3, 2015

Cryoport Supports South Mountain Pet Care with Cryogenic Logistics Solutions

PR Newswire May 27, 2015

Cryoport Reports Record Revenues For Fourth Quarter and Fiscal Year 2015

PR Newswire May 19, 2015

Cryoport to Present its FY2015 Results and Business Update at the 2015 Marcum MicroCap Conference

PR Newswire May 7, 2015

Cryoport Supports NeoStem's Intus Study for the Treatment of Metastatic Melanoma

PR Newswire April 29, 2015

Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms

PR Newswire April 23, 2015

Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA

PR Newswire April 21, 2015